[Federal Register Volume 63, Number 67 (Wednesday, April 8, 1998)]
[Notices]
[Page 17192]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-9226]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Heart, Lung, and Blood Institute meetings:
Name of Committee: Clinical Trials Review Committee.
Date: June 21-23, 1998.
Time: 7:00 p.m.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center,
Bethesda, Maryland 20814.
Contact Person: Joyce A. Hunter, Ph.D., Two Rockledge Center,
Room 7192, 7601 Rockledge Drive, Bethesda, Maryland 20982-7924,
(301) 435-0287.
Purpose/Agenda: To review and evaluate Clinical Trial and R03
grant applications.
Name of Committee: National Heart, Lung, and Blood Special
Emphasis Panel (A Related Umbilical Cord Blood Bank for
Hemoglobinopathy Patients)--Telephone Conference Call.
Date: May 11, 1998.
Time: 2:00 p.m.
Place: Rockledge Center II, Room 7214, 6701 Rockledge Drive,
Bethesda, Maryland 20892-7924.
Contact Person: Camille King, Ph.D., Two Rockledge Center, Room
7208A, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301)
435-0321.
Purpose/Agenda: To review and evaluate grant applications.
Name of Committee: National Heart, Lung, and Blood Special
Emphasis Panel (Immunogenetics of Inhibitor Formation in Hemophilia.
Date: June 15, 1998.
Time: 8:00 a.m.
Place: Holiday Inn Silver Spring, 8777 Georgia Avenue, Silver
Spring, Maryland 20910.
Contact Person: Deborah Beebe, Ph.D., Two Rockledge Center, Room
7178, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301)
435-0270.
Purpose/Agenda: To review and evaluate grant applications.
These meetings will be closed in accordance with the provisions
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart
and Vascular Diseases Research; 93.838, Lung Diseases Research; and
93.839, Blood Diseases and Resources Research, National Institutes
of Health.)
Dated: April 2, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-9226 Filed 4-7-98; 8:45 am]
BILLING CODE 4140-01-M
